stephen
b
greenberg
md
patient
chronic
obstruct
pulmonari
diseas
copd
elderli
individu
prone
develop
signific
lower
respiratori
tract
symptom
cold
caus
viral
respiratori
pathogen
longitudin
surveil
studi
conduct
assess
impact
viral
respiratori
tract
pathogen
morbid
mortal
atrisk
popul
demonstr
substanti
burden
diseas
viral
respiratori
infect
vri
includ
rhinoviru
infect
respect
util
healthcar
resourc
despit
similar
rate
occurr
vri
among
subject
copd
control
group
cohort
moder
sever
copd
increas
medic
resourc
util
includ
clinician
visit
emerg
center
visit
hospit
surveil
studi
respiratori
virus
elderli
regular
season
infect
rhinovirus
caus
substanti
morbid
larg
underappreci
underreport
popul
unit
state
age
predict
year
estim
million
million
us
citizen
year
age
older
individu
age
increas
morbid
mortal
associ
mani
medic
condit
often
result
increas
util
medic
resourc
reprint
greenberg
contribut
viral
respiratori
infect
vri
morbid
elderli
peopl
underli
pulmonari
diseas
wide
describ
appreci
respect
util
medic
servic
burden
diseas
vri
substanti
chronic
obstruct
pulmonari
diseas
copd
elderli
longitudin
studi
peopl
age
older
rhinoviru
infect
nearli
develop
lower
respiratori
tract
ill
similar
rate
document
patient
chronic
lung
diseas
copd
patholog
medic
condit
affect
estim
million
peopl
fourth
lead
caus
death
unit
state
preval
copd
expect
increas
popul
age
copd
character
nonrevers
progress
airflow
limit
includ
obstruct
bronchiti
emphysema
mucu
plug
loss
lung
elast
closur
small
airway
patient
copd
use
medic
resourc
total
billion
per
year
acut
exacerb
copd
frequent
caus
hospit
admiss
subsequ
ill
exacerb
copd
often
prolong
profound
impact
qualiti
life
morbid
death
per
copd
quadrupl
past
year
unit
state
wherea
ageadjust
death
rate
caus
decreas
although
virus
caus
acut
respiratori
ill
patient
copd
similar
recov
otherwis
healthi
adult
studi
suggest
patient
copd
increas
ill
rate
andor
may
suscept
ill
caus
specif
virus
deterior
pulmonari
function
exacerb
copd
may
due
viral
bacteri
mix
viralbacteri
pathogen
respiratori
tract
patient
copd
recov
slowli
without
copd
reason
entir
clear
specul
recoveri
may
slow
unexplain
pathophysiolog
mechan
includ
mucos
damag
diseas
deterior
lung
function
releas
histamin
inflammatori
mediat
recent
studi
seemung
et
al
report
higher
level
patient
copd
exacerb
slower
clinic
recoveri
virusproven
infect
role
vri
elderli
adult
without
copd
evalu
longitudin
cohort
studi
conduct
septemb
april
defin
caus
frequenc
sever
ill
util
medic
care
servic
studi
patient
enrol
fulli
evalu
pulmonari
function
subject
assess
baselin
spirometri
use
stratifi
subject
control
subject
histori
copd
copd
group
subject
mild
copd
moder
sever
copd
patient
recruit
local
privat
physician
hospit
pulmonari
clinic
hospit
registri
older
person
control
subject
baselin
forc
expiratori
volum
second
fev
greater
predict
group
mild
copd
baselin
fev
greater
less
predict
group
moder
sever
copd
baselin
fev
less
predict
approxim
studi
subject
receiv
vaccin
influenza
rang
patient
demograph
summar
tabl
subject
copd
group
discontinu
studi
prematur
compar
control
p
significantli
subject
control
group
copd
group
follow
winter
season
p
three
subject
copd
group
follow
less
complet
fallwint
season
earli
studi
termin
similar
group
subject
request
common
reason
discontinu
follow
death
subject
residenti
move
state
loss
followup
picornavirus
common
viral
pathogen
identifi
studi
follow
parainfluenza
virus
coronavirus
seventyf
percent
picornavirus
identifi
rhinovirus
rhinovirus
coronavirus
caus
viru
infect
experienc
control
group
account
viru
infect
group
copd
statist
signific
differ
frequenc
viru
isol
copd
control
subject
tabl
acut
respiratori
ill
occur
frequent
among
subject
moder
sever
copd
acut
respiratori
ill
per
year
compar
mild
copd
acut
respiratori
ill
per
year
control
acut
respiratori
ill
per
year
p
annual
rate
virusproven
respiratori
ill
significantli
differ
control
subject
ill
per
year
subject
copd
ill
per
year
identif
frequenc
virus
symptom
clinic
syndrom
assess
upper
lower
respiratori
tract
ill
caus
document
viru
infect
common
upper
respiratori
tract
ill
urti
lower
respiratori
tract
ill
lrti
urti
includ
rhiniti
laryng
pharyng
lrti
defin
increas
cough
short
breath
chang
sputum
product
color
among
control
subject
picornaviru
rhiniti
pharyng
laryng
clinic
syndrom
subject
copd
confirm
picornaviru
includ
follow
urti
rhiniti
pharyng
laryng
overal
control
subject
present
higher
percentag
urti
subject
copd
tabl
viru
identif
rate
similar
control
subject
subject
copd
sign
symptom
urti
control
subject
subject
copd
symptomat
subject
mix
urti
lrti
virus
identifi
control
subject
copd
cohort
p
recent
similar
studi
use
pcr
techniqu
respiratori
virus
identifi
group
patient
chronic
bronchiti
follow
longitudin
acut
respiratori
ill
atmar
rl
bandi
v
greenberg
sb
unpublish
observ
picornavirus
account
viralproven
ill
similar
studi
patient
copd
london
detect
respiratori
virus
exacerb
vri
detect
month
year
although
total
number
respiratori
ill
control
subject
peak
winter
month
decemb
januari
februari
ill
copd
group
occur
longer
durat
studi
greenberg
et
al
compar
vri
adult
without
copd
increas
start
septemb
remain
elev
may
figur
median
durat
ill
day
patient
copd
importantli
even
though
influenza
viru
circul
commun
evalu
period
major
virusassoci
ill
heavili
vaccin
control
copd
group
result
influenza
viru
although
influenza
immun
complet
prevent
infect
ill
other
demonstr
decreas
sever
complic
hospit
immun
adult
coronaviru
infect
frequent
identifi
hospit
patient
hospit
among
studi
group
result
influenza
subject
moder
sever
copd
access
medic
care
frequent
control
subject
mild
copd
fiftyeight
percent
total
copd
cohort
control
subject
least
offic
visit
vri
p
six
percent
total
copd
cohort
seen
emerg
center
subject
moder
sever
copd
hospit
subject
moder
sever
copd
control
subject
requir
emerg
care
hospit
despit
similar
rate
occurr
vri
among
subject
copd
control
group
cohort
moder
sever
copd
increas
medic
resourc
util
includ
clinician
visit
emerg
center
visit
hospit
larg
communitybas
surveil
studi
perform
nicholson
et
al
assess
role
rhinovirus
cohort
ambulatori
subject
age
older
anoth
studi
assess
medic
burden
diseas
viral
sourc
infect
identifi
pathogen
identifi
episod
document
respiratori
ill
pathogen
identifi
upper
respiratori
episod
rhinoviru
preval
pathogen
isol
fiftynin
coronavirus
identifi
follow
influenza
virus
isol
respiratori
syncyti
viru
tabl
ual
viru
infect
observ
isol
rhinovirus
common
type
viru
found
isol
dual
infect
median
durat
ill
day
durat
ill
longer
elderli
person
lower
respiratori
tract
symptom
day
vs
day
ninetyeight
percent
subject
describ
upper
respiratori
tract
symptom
lower
respiratori
tract
symptom
system
symptom
distinguish
symptom
characterist
differenti
one
type
viral
infect
anoth
age
sex
smoke
statu
infect
subject
compar
regardless
viru
identifi
activ
restrict
rhinoviru
infect
hospit
uncommon
medic
care
sought
subject
approxim
hour
initi
symptom
rhinovirusinfect
subject
sought
medic
care
antimicrobi
prescrib
empir
medic
consult
primarili
suspect
lrti
nicholson
et
al
use
regress
analysi
identifi
increas
risk
lower
respiratori
tract
diseas
littl
known
risk
factor
immunopatholog
pathophysiolog
mechan
trigger
lower
respiratori
episod
rhinovirus
associ
lower
respiratori
tract
ill
often
elderli
subject
current
smoker
chronic
lung
diseas
underli
medic
condit
elderli
subject
rhinovirus
respons
greater
diseas
burden
influenza
diseas
burden
defin
restrict
activ
greater
frequenc
durat
ill
burdenofdiseas
measur
use
comparison
method
develop
us
institut
medicin
committe
issu
prioriti
new
vaccin
develop
diseas
import
unit
state
investig
conclud
morbid
mortal
season
infect
rhinovirus
coronavirus
respiratori
syncyti
viru
underestim
overshadow
readili
recogniz
epidem
influenza
vri
among
elderli
also
well
document
institut
set
wald
et
al
describ
passiv
surveil
studi
larg
rhinoviru
outbreak
among
institution
elderli
resid
longtermcar
facil
overal
ill
vari
sever
seriou
lower
respiratori
tract
involv
appar
sever
person
copd
new
onset
lower
respiratori
tract
symptom
document
infect
person
attribut
rhinoviru
infect
picornavirus
specif
rhinovirus
import
viral
respiratori
tract
pathogen
caus
increas
exacerb
morbid
patient
copd
elderli
rhinovirus
implic
vri
ambulatori
elderli
well
longtermcar
facil
rhinovirus
associ
higher
incid
lower
respiratori
ill
elderli
account
higher
number
clinician
visit
activ
restrict
signific
number
antibiot
prescript
patient
popul
hospit
vri
result
rhinoviru
may
increas
among
subject
moder
sever
copd
increas
preval
vulner
highrisk
patient
copd
grow
popul
elderli
societi
newer
antivir
agent
need
prophylaxi
common
viral
respiratori
tract
infect
